Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Bevacizumab With FOLFOX or FOLFIRI.

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

May 31, 2019

Study Completion Date

May 31, 2019

Conditions
Metastatic Colorectal Cancer
Interventions
PROCEDURE

Metastases resection

Surgery of colorectal cancer metastases will be proceeded after 3 to 6 cycles of chemotherapy ( folfox or folfiri) + bevacizumab .

DRUG

Bevacizumab

Bevacizumab 5 mg/kg in 100 ml NaCl 0.9% IV infusion 3 to 5 cycles. No bevacizumab for ultimate cycle .

DRUG

5 FU

Leucovorin L (levoleucovorin) 200 mg/m2 (or folinic acid 400 mg/m²) in 250 ml glucose 5%, IV infusion 3 to 6 cycles 5-FU bolus 400 mg/m2, IV bolus 3 to 6 cycles 5-FU continuous infusion 2400 mg/m2, 46-hour cont. IV infusion 3 to 6 cycles

DRUG

Oxaliplatin

oxaliplatin 85 mg/m² in 150 ml NaCl 0.9%, IV infusion 3 to 6 cycles

DRUG

Irinotecan

Irinotecan 180 mg/m² in 150 ml NaCl 0.9%, IV infusion 3 to 6 cycles

Trial Locations (11)

1180

CHIREC, Brussels

1200

Cliniques universitaires Saint-Luc, Brussels

1340

Clinique Saint Pierre Ottignies, Ottignies

4000

CHC Liège clinique Saint Joseph, Liège

CHU liège (Sart Timan), Liège

5000

Clinique Maternité Saint Elisabeth, Namur

5004

Clinique Saint Luc, Bouge

5530

CHU-UCL Dinant-Godinne, Yvoir

6000

Grand Hopital de Charleroi, Charleroi

7100

Centre Hospitalier Jolimont Lobbes, La Louvière

8500

AZ Groeninge, Kortrijk

All Listed Sponsors
collaborator

Grand Hôpital de Charleroi

OTHER

lead

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

OTHER

NCT01858649 - Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Bevacizumab With FOLFOX or FOLFIRI. | Biotech Hunter | Biotech Hunter